Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium (RPE) patch to cure ...

(“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development ...

The DISCOVER Phase 1/2a trial is an open-label, single ascending dose, 9-month study that will evaluate the safety and bioactivity of AXT107 ...

Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease ...

Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study ...

A recent study found home-monitoring tests as a potential solution to reduce the burden of neovascular age-related macular ...

Spirulina and chlorella are types of microalgae commonly taken in supplement form. They share some benefits, but they each offer unique properties.

EyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase 2 study for its eye drug ...

A couple of beers after work or a half-bottle of wine at dinner is a beloved Aussie tradition, but new findings from a ...

“Sight Beyond Limits”: On display through May. The Mandelbaum and Ambert Family Vision Gallery is located on the 9th floor, ...

To provide opportunity for encouragement, Phoenix-based Associated Retina Consultants, in coordination with the International ...

Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with STGD1 and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration ...